STOCK TITAN

22nd Century Group to Participate in the Emerging Growth Virtual Conference on August 21, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

22nd Century Group (NASDAQ: XXII), a tobacco products company specializing in nicotine harm reduction and contract manufacturing, has announced its participation in the Emerging Growth Virtual Conference on August 21, 2024. The company will provide a brief corporate update during the event at 4:25 PM Eastern Time.

Investors and interested parties can access the live presentation through the events link available on the company's investor relations website at https://ir.xxiicentury.com/. This virtual conference appearance offers an opportunity for 22nd Century Group to showcase its latest developments and strategies in the tobacco industry, particularly in the areas of reduced-risk products and manufacturing services.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.79% News Effect

On the day this news was published, XXII declined 1.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Mocksville, North Carolina--(Newsfile Corp. - August 20, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it will provide a brief corporate update as part of the Emerging Growth Virtual Conference on Wednesday, August 21, 2024 at 4:25 PM Eastern Time.

To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.

About 22nd Century Group, Inc.
22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction by offering tobacco products with 95% less nicotine, designed to improve health and wellness by helping smokers smoke less. Backed by comprehensive and extensively patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, the Company has pioneered the development of high-yield, proprietary reduced nicotine content (RNC) tobacco plants and clinically validated RNC cigarette products. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. The Company is a subsequent participating manufacturer under the Master Settlement Agreement ("MSA") and vertically integrated for the production of both its own products and contract manufacturing operations ("CMO"), which consist primarily of branded filtered cigars and conventional cigarettes.

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.

Learn more about VLN® at tryvln.com.

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/220619

FAQ

When is 22nd Century Group (XXII) participating in the Emerging Growth Virtual Conference?

22nd Century Group (XXII) is participating in the Emerging Growth Virtual Conference on August 21, 2024 at 4:25 PM Eastern Time.

How can investors access 22nd Century Group's (XXII) presentation at the Emerging Growth Virtual Conference?

Investors can access 22nd Century Group's (XXII) live presentation through the events link available on the company's investor relations website at https://ir.xxiicentury.com/.

What is the focus of 22nd Century Group's (XXII) business?

22nd Century Group (XXII) is a tobacco products company focused on nicotine harm reduction and contract manufacturing.

What stock exchange is 22nd Century Group (XXII) listed on?

22nd Century Group (XXII) is listed on the NASDAQ stock exchange.
22Nd Century

NASDAQ:XXII

XXII Rankings

XXII Latest News

XXII Latest SEC Filings

XXII Stock Data

5.38M
6.68M
1.91%
0.88%
2.77%
Tobacco
Cigarettes
Link
United States
WILLIAMSVILLE